PIL for CBI probe into politicians procuring Remdesivir mentioned in HC

The plea questions how politicians are able to procure the medicine without having the requisite permission under the Drugs and Cosmetics Act, when the general public was not getting it

Remdesivir
The plea was mentioned before a bench of Justices Vipin Sanghi and Rekha Palli by advocate Virag Gupta (Photo: PTI)
Press Trust of India New Delhi
2 min read Last Updated : May 01 2021 | 12:42 PM IST
The plea questions how politicians are able to procure large stocks of the medicine without having the requisite permission under the Drugs and Cosmetics Act, when the general public was not getting it

A PIL demanding an FIR and CBI probe into claims of politicians being able to procure and distribute Remdesivir, used for treating coronavirus (Covid-19) patients, even as others run pillar to post to get the medicine, was mentioned before the Delhi High Court on Saturday.

The plea was mentioned before a bench of Justices Vipin Sanghi and Rekha Palli by advocate Virag Gupta who was asked by the court to bring the petition on record during the day.

The plea questions how politicians are able to procure large stocks of the medicine without having the requisite permission under the Drugs and Cosmetics Act, when the general public was not getting it.

Petitioner Deepak Singh, the chairperson of Hruduya Foundation and a national-level shooter, has contended that "denying access to medicines for one's own political gain is a crime of very serious nature, and affects coronavirus patients all over India".

Singh has alleged in his plea, filed through advocate Gaurav Pathak, that politicians have been involved in large-scale hoarding, transfer and distribution of crucial medicines like Remdesivir.

"Political parties, most of which are invariably headquartered in Delhi, are taking advantage of their political powers and giving patronage to the medical mafia," the plea claimed.

Besides lodging of FIR and CBI invetsigation, the plea also seeks "detention of persons indulging in black-marketing of Covid-19 medicines as per the National Security Act, 1980" and "disqualification of MPs and MLAs found to be hoarding and illegally distributing Covid-19 medicines".

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story